Latest

Multiple Sclerosis

·June 13, 2023·5 min read

Antihistamine Sparks Hope for Myelin Repair in Multiple Sclerosis

A new study paves the way for potential treatments for Multiple Sclerosis (MS) by identifying the OTC antihistamine, clemastine, as an effective drug for brain repair. Utilizing a newly-developed MRI scan technique, scientists were able to observe and measure the impact of clemastine on brain myelin levels.

Featured Neurology Neuroscience

·May 25, 2023·6 min read

Loosely Wrapped Myelin Marks Early Stages of Multiple Sclerosis, Even Before Inflammation

Structural abnormalities in white matter, even before the onset of inflammation, may serve as a new therapeutic target for multiple sclerosis (MS). The study, focusing on 'normal-appearing white matter', identified early changes in myelin, an insulating substance around nerve fibers.

Featured Neurology Neuroscience

·May 17, 2023·5 min read

Epstein-Barr Virus Antibodies Linked to Multiple Sclerosis Progression

Researchers have discovered a new link between the Epstein-Barr virus (EBV) and the progression of multiple sclerosis (MS). Their study revealed that certain antibodies, originally aimed at fighting EBV, can mistakenly target proteins in the brain and spinal cord, leading to MS symptoms. This antibody misdirection was found in roughly 23% of MS patients studied. The findings highlight the need for personalized therapies to combat MS.

Featured Neurology Neuroscience

·May 3, 2023·5 min read

Pilot Study Shows Promise for Remote Aerobic Walking Exercise in Improving Cognitive Function for People with Multiple Sclerosis

Remote aerobic walking exercise training can improve cognitive processing speed impairment in fully ambulatory persons with multiple sclerosis (MS). The results are promising for individuals with MS who experience cognitive processing speed impairment and provide a more inclusive solution for remote exercise programs.

Featured Neurology Neuroscience

·April 20, 2023·2 min read

Multiple Sclerosis Drug May Delay Earliest Symptoms

Early intervention with the multiple sclerosis treatment Teriflunomide delays the preliminary symptoms of the autoimmune disease, a new study reports. Those who took teriflunomide had a 72% lower risk of experiencing the initial symptoms of MS than those who took a placebo.

Featured Neurology Neuroscience

·March 28, 2023·5 min read

Bacterial Toxin May Trigger Multiple Sclerosis Onset and Relapse

Findings reveal a toxin-producing gut bacteria may be responsible for triggering the onset of multiple sclerosis and play a significant role in the progression of the disease.

Featured Neurology Neuroscience

·March 5, 2023·3 min read

Can Mediterranean Diet Help People With Multiple Sclerosis Preserve Thinking Skills?

For those with multiple sclerosis, following a Mediterranean diet may help lower the risk of developing cognitive, memory, and thinking problems.

Featured Neurology Neuroscience

·February 25, 2023·6 min read

‘Usual Suspect’ Lesions Appear Not to Cause Most Severe Disability in Multiple Sclerosis Patients

While brain lesions may be a key marker for Multiple Sclerosis, they may not actually be drivers of disability progression, a new study reports.

Featured Neurology Neuroscience

·February 15, 2023·4 min read

Multiple Sclerosis Discovery Could End Disease’s Chronic Inflammation

Blocking the activity of the reactor called the aryl hydrocarbon receptor in T cells resulted in both a decrease in inflammation and recovery in mouse models of multiple sclerosis.

Featured Neurology Neuroscience

·February 9, 2023·5 min read

New Biomarker for Disease Progression in Multiple Sclerosis

The blood level of the glial fibrillary acidic protein (GFAP) cellular component increases when astrocytes are damaged or activated. Elevated levels of GFAP in the blood can indicate both the current and future progression of multiple sclerosis.

Featured Neurology Neuroscience

·January 24, 2023·4 min read

How a Brain Molecule Could Halt Multiple Sclerosis

Injecting the brain molecule into mouse models of multiple sclerosis increased the number of oligodendrocytes. The findings suggest fractalkine may help to slow the progression, or potentially halt multiple sclerosis.